CompletedNot Applicable

Fat Oxidation Capacity in Patients With Post Covid-19 Syndrome

Germany187 participantsStarted 2021-04-01

Plain-language summary

Post-COVID-19 Syndrome (PCS) is characterized by symptoms, including fatigue, reduced physical performance, dyspnea, cognitive impairment, and psychological distress. The mechanisms underlying the onset and severity of PCS point to mitochondrial dysfunction as significant contributor. This study examined fat oxidation as a function of mitochondrial capacity during exercise.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * a history of (at least one) Covid-19 infection * ongoing or newly expressed performance deficits lasting for at least 3 months prior to recruitment * referral to inpatient rehabilitation * signed informed consent Exclusion Criteria: * unstable condition * incapable of understanding study information

What they're measuring

Change in Fat Oxidation Rate

Timeframe: Baseline and week 4 (i. e. before discharge)

Trial details

NCT IDNCT06468722

SponsorUniversity of Witten/Herdecke

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-06-30

View on ClinicalTrials.gov More Post-COVID-19 Syndrome trials